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Abstract
Background: In those receiving radiotherapy for pelvic cancers, up to 80% develop gastrointestinal
symptoms, with dietary interventions recommended to reduce these symptoms. However, research outlining
the current dietary support provided to patients undergoing radiotherapy for pelvic cancer is lacking.
Aim: To identify the gastrointestinal symptoms experienced by those undergoing pelvic radiotherapy and to
identify the dietary support provided to these patients.
Methods and materials: A service evaluation was undertaken in one NHS Trust hospital whereby patients
undergoing radical pelvic radiotherapy during a 15-week recruitment period were invited to complete an
anonymous questionnaire. Participants were recruited using purposive sampling and the data were analysed
descriptively using SPSS.
Results: In total, 31 patients responded achieving a response rate of 48%. The most frequent reported
gastrointestinal symptoms were gas and ﬂatulence followed by diarrhoea, nausea and abdominal pain. The
main dietary changes implemented by the respondents and recommended by health care professionals
included reducing ﬁbre intake, reducing certain vegetables, reducing caffeine and increasing water.
Findings: The results illustrate the impact of gastrointestinal side effects on patients’ dietary intake. The results
highlight that nutritional guidance need to be standardised, especially for the management of diarrhoea and gas
and ﬂatulence as these were the most common occurring side effects. With radiographers most frequently giving
nutritional advice they must be provided with guidance to support those undergoing pelvic radiotherapy.
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INTRODUCTION
Radiotherapy is the use of ionising radiation to
treat illness and is an important treatment for
cancer.1 Within the United Kingdom, ~30,000
patients undergo pelvic radiotherapy each year.1
The most common physical side effects occurring
among those undergoing pelvic radiotherapy
are gastrointestinal symptoms.2,3 These include
diarrhoea or constipation, abdominal pain,
nausea, steatorrhoea, bloating and weight loss,
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negatively affecting patients’ quality of life
(QOL).4–7
The challenge of radiotherapy is to ensure an
adequate dose of radiation is delivered to the
treatment area, while sparing normal non-
cancerous tissue to avoid side effects.8 Radiation
damage occurs in cells undergoing mitosis
resulting in apoptosis, autophagy, senescence and
necrosis, all activated to different extents in dif-
ferent tissues and genetically controlled leading
to an inﬂammatory process resulting in side
effects.9 Cells with a quicker turnover are more
vulnerable to the effects of radiation. With the
intestinal mucosa repopulating its cells every
5 days, it is vulnerable to radiation damage with
gastrointestinal symptoms usually beginning
during the second week of treatment.10
Chemotherapy also damages the rapidly turning
over gastrointestinal tract epithelium, further pre-
disposing patients to gastrointestinal side effects.11
The inﬂammatory response of the gastrointestine
to irradiation ﬂattens the intestinal microvilli
decreasing enzymatic activity, absorptive surface
area and total gut transit time leading to pelvic
symptoms and malabsorption of nutrients.12–14
Dietary support is one approach in managing
some of these patients’ symptoms and is non-
invasive and low cost.15 However, despite this,
the current nutritional advice for managing bowel
side effects following pelvic radiotherapy is
inconsistent and lacks standardised guidelines.6,16
Nutritional interventions suggested in the litera-
ture include reducing ﬁbre, fat and lactose, and
administering probiotics for managing symptoms
on the premise that malabsorption of fat, lactose,
carbohydrate and small bowel bacterial over-
growth occurs following radiotherapy.4,6,17,18
Following an electronic search of databases, no
studies were identiﬁed that investigated the cur-
rent dietary advice provided clinically to patients
who suffer from gastrointestinal symptoms fol-
lowing radiotherapy. Therefore, it is unknown if
the needs of these patients are being met. In the
absence of nutrition advice, patients may imple-
ment their own coping strategies including
decreasing dietary intake or self-imposing
restricted diets potentially leading to a nutri-
tionally inadequate diet.14 Minimising food
restriction is important because malnutrition is an
adverse prognostic factor in most cancers and as
up to 33% of patients are malnourished at the
start of pelvic radiotherapy minimising the pro-
gression of this is important.6
In order to develop practical guidance on the
use of nutrition support it is important to know
what nutritional support is being provided to
those who have undergone pelvic radiotherapy.
Therefore, the overall aim of this study was to
investigate patients’ experience regarding the
management of gastrointestinal symptoms during
pelvic radiotherapy with a particular focus on
nutritional management. The objectives were to
∙ establish which patients experienced gastro-
intestinal side effects;
∙ evaluate the service provided by heath care
providers regarding nutritional advice to patients
who have undergone pelvic radiotherapy;
∙ evaluate if patients’ dietary intake has been
affected by radiotherapy.
Ethical approval
Ethical approval was obtained from the
University of Worcester. As this study was
deemed a service evaluation it did not require
NHS ethical approval.19 However, permission
was granted by the NHS Trust Research and
Development department. This research study
was undertaken in line with the Data Protection
Act 199820,21 and anonymity was assured
through the use of an anonymous questionnaire.
METHODS
A cross-sectional study was undertaken with
participants undergoing pelvic radiotherapy in a
single NHS Trust, with the use of purposive
sampling. A cross-sectional survey was used to
investigate a sample that is representative of a
population.22 In this instance, patients under-
going pelvic radiotherapy in the same Trust.
A self-completion postal questionnaire was
designed to meet the study’s overall aim
(Appendix A). The questionnaire was developed
based on the questionnaires used by Henson
et al.,16,23 the Picker Patient Experience
Questionnaire-1524
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and the patient experience questionnaire,25
which are reliable and validated measures of
patient experience.24,25
The questionnaire was not piloted among
those representing the study population due to
the likely small sample size and time constraints,
however, it was developed and piloted among
those with a background in radiotherapy and
nutrition to identify any potential problems.
Potential participants were selected according
to meeting the inclusion and exclusion criteria.
Inclusion criteria:
∙ All patients over 18 years undergoing radical
pelvic radiotherapy.
∙ Patients willing to participate.
∙ Ability to read and write in English.
Exclusion criteria:
∙ Those undergoing palliative treatment.
∙ Those unwilling to participate.
∙ Those considered inappropriate for inclusion
by clinical oncology consultant.
∙ Age <18 years.
∙ Patients unable to complete patient-reported
questionnaires.
The principal investigator approached all par-
ticipants meeting the inclusion criteria towards the
end of their treatment outlining the research and
why they have been asked to participate. This was
carried out from the October 2015 to January
2016. Participants were provided with a pack
including the questionnaire, participant informa-
tion leaﬂet and stamped addressed envelope.
Consent was implied by the return of the
questionnaire. During the time of data collection,
65 patients were provided with a questionnaire,
31 were returned giving a response rate of 48%.
The responses were coded, entered and
analysed using the statistical package SPSS version
16. Descriptive analysis was undertaken to repre-
sent data numerically and provide frequencies,
percentages, means and standard deviations.
To investigate relationships between variables a
Fisher’s exact test was used. A p value ≤0·05 was
used. Qualitative data obtained from open-ended
questions in each questionnaire were summarised
in groups and put into tables. The main points are
illustrated below using selected coded extracts and
quotations.
RESULTS
Table 1 summarises the characteristics of the 31
participants. The majority of respondents were
male, having undergone treatment for prostate
cancer, with the other respondents having
undergone treatment for endometrial, cervical or
bowel cancer. Four of the participants had
undergone chemotherapy, three of which had
bowel cancer and one cervical cancer. Table 2
outlines the reported incidence of gastrointestinal
side effects among each cancer group. Only one
respondent stated that he did not suffer from any
gastrointestinal side effects. No signiﬁcant rela-
tionships were found between age, gender,
diagnosis and chemotherapy and the occurrence
of gastrointestinal side effects. Although all
female patients (n = 5) experienced diarrhoea,
this was not statistically signiﬁcant (p = 0·07).
Three of the four patients who had
chemotherapy-experienced diarrhoea, but this
was not statistically signiﬁcant (p = 0·639).
In total, 18 respondents (58%) made changes
to their diet to alleviate bowel symptoms, which
involved omitting certain foods, increasing water
intake, eating less food and drinking herbal teas.
Table 1. Participant characteristics
Male Female Total
No. of participants 26 (84%) 5 (16%) 31
Median age (years) 70 64
Age range 53–90 34–73
Cancer site
Prostate 23 (74%) 0 23
Endometrial 0 3 (10%) 3
Bowel (three rectal and one anal) 3 (10%) 1 (3%) 4
Cervical 0 1 (3%) 1
Time since ﬁnished Radiotherapy
(weeks)
0–2 weeks after treatment 24 (77%) 4 (13%) 28
3–4 weeks after treatment 0 1 (3%) 1
5–6 weeks after treatment 0 0 0
More than 6 weeks after
treatment
2 (6%) 0 2
Received chemotherapy 2 (6%) 2 (6%) 4
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This was a result of experiencing reduced
appetite and restricting certain foods which
aggravated their symptoms. The following
comments are illustrative of this ﬁnding.
‘Sometimes not wanting food or just a little’
(66-year-old male with bowel cancer).
‘From week four needed to almost completely
remove dietary ﬁbre’ (65-year-old male with
prostate cancer).
For the management of diarrhoea, eight (40%)
made dietary changes including reducing ﬁbre
intake, reducing certain vegetables and caffeine.
Of the 24 that suffered with gas 12 (50%) imple-
mented dietary changes with seven stating this
helped ease the gas, one stated ‘no’ and four stated
‘a little’. The changes made by patients to alleviate
gas and ﬂatulence included drinking herbal teas,
reducing ﬁbre, reducing ﬁzzy drinks and omitting
pulses from their diet.
‘Reduced ﬁbre, cut out ﬁzzy drinks’ (34-year-old
femalewith cervical cancer), which she stated helped.
‘White bread instead of brown, green veg
avoided, tea and coffee avoided, raw fruit avoi-
ded, cereals avoided’ (73-year-old female with
endometrial cancer), which she stated helped.
One of the objectives of this service evaluation
was to evaluate if and what nutritional advice is
provided to patients by health care professionals
(HCPs). Radiographers were the most frequently
cited HCPs from whom patients received dietary
information with some respondents stating they
got advice regarding management of bowel side
effects from a doctor and a nurse.
The dietary advice provided to 13 patients to
help alleviate diarrhoea is outlined in Figure 1.
Out of the nine respondents who were advised to
change their dietary ﬁbre intake six wrote what
this advice was, which included both increasing
ﬁbre and reducing ﬁbre. The advice provided by
HCPs to help alleviate nausea are outlined in
Figure 2.
In total, 17 patients received dietary advice to
help alleviate gas. This was a multiple choice
question and the dietary advice provided and the
frequency of such advice is illustrated in Figure 3.
Two received ‘other’ information which was to
‘eat regularly and avoid large meals’ and use
Table 2. Incidence of side effects among respondents
Cancer diagnosis
Prostate (n = 23) Endometrial (n = 3) Bowel (n = 4) Cervical (n = 3) Total
Side effect
Diarrhoea 13 (56%)a 3 (100%) 3 (75%) 1 (100%) 20 (65%)b
Nausea 2 (9%) 1 (33%) 0 1 (100%) 4 (13%)
Gas and ﬂatulence 18 (78%) 2 (67%) 3 (75%) 1 (100%) 24 (77%)
Abdominal pain 5 (22%) 1 (33%) 1 (25%) 0 7 (22%)
Side effect ongoing
Diarrhoea 6 (26%) 1 (33%) 1 (25%) 1 (100%) 9 (29%)
Nausea 1 (4%) 1 (33%) 0 1 (100%) 3 (10%)
Gas and ﬂatulence 9 (39%) 0 2 (50%) 0 11 (35%)
Abdominal pain 2 (9%) 1 (33%) 1 (25%) 0 4 (13%)
Notes: aPercentage refers to percentage of those with that cancer.
bPercentage refers to percentage of all patients (n = 31).
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Figure 1. Dietary advice provided by health care professional to
alleviate diarrhoea.
Dietary advice provided to those undergoing pelvic radiotherapy
4
https://doi.org/10.1017/S1460396917000073
Downloaded from https:/www.cambridge.org/core. Fromageries Bel, on 24 Feb 2017 at 13:26:00, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
‘peppermint capsules’. Of the six patients who
suffered with abdominal pain, four received diet-
ary advice from a HCP who was a radiographer in
all cases. The advice provided is shown in Figure 4.
DISCUSSION
Incidence of side effects
In this study, 97% of the participants suffered
from gastrointestinal side effects, likewise
Andreyev26 reports that up to 80% develop early
gastrointestinal symptoms. Similar to other
studies, gas and ﬂatulence was the most common
reported gastrointestinal symptom followed by
diarrhoea, abdominal pain and nausea.4,6
Although a small sample (n = 4) all of those
with gynaecological cancer and 75% (n = 3) of
those with bowel cancer experienced diarrhoea.
As this is a small sample it cannot be assumed that
all patients undergoing pelvic radiotherapy for
gynaecological and bowel cancer experience
diarrhoea. However, with a larger area of the
gastrointestine irradiated in those with gynaeco-
logical and bowel cancer this further causes
gastrointestinal symptoms.27 In addition, those
with gynaecological and bowel often receive
chemotherapy, as was the case in the current
study, and therefore consideration should be
made to ensure these patients are closely mon-
itored for side effects and early intervention
implemented as appropriate as these side effects
can negatively impact patients’ QOL.5
Dietary interventions implemented
by patients
In total, 18 (58%) of the patients in the present
study made dietary changes to alleviate bowel
symptoms. These ﬁndings as listed above are
similar to other research.5,9,28,29 Although in the
present study the majority of patients stated the
dietary changes helped alleviate symptoms one
limitation was that respondents could select a
number of dietary changes implemented and
therefore it was not possible to identify which
dietary change improved symptoms.
Dietary advice provided by HCPs
Oncology practice advises a low-ﬁbre diet during
the course of radiotherapy to manage gastro-
intestinal symptoms,6 as the ﬁndings in the present
study show. Although there was some contrast,
with some patients advised to increase ﬁbre and
others advised to decrease it the majority were
advised to reduce ﬁbre intake. Those with cancer
receive a wide range of advice from many sources
about foods they should eat and avoid, and often
this advice is conﬂicting.30 This highlights the
need for the development of deﬁnitive guidance
on the nutritional management of gastrointestinal
side arising from radiotherapy.
Although reducing ﬁbre intake is commonly
advised to patients, omitting all ﬁbre may worsen
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Figure 2. Dietary advice provided by health care professional to
alleviate nausea.
0 4 6 8 10 12 14
Other
Reduce Spicy Food
Reduce Caffeine
Omit Alcohol
Reduce Fizzy Drinks
Increase Water
Ginger Tea
Peppermint Tea
Reduce Latose
Reduce Pulses
Reduce Dietary Fat
Change Veg Intake
Change Fruit Intake
Change Fibre Intake
Number of Respondents who received Advice
D
ie
ta
ry
 A
dv
ice
2
Figure 3. Dietary advice provided by health care professional to
alleviate gas.
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Figure 4. Dietary advice provided by health care professional to
alleviate abdominal pain.
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patients’ diarrhoea because the intake of dietary
ﬁbre can help alleviate diarrhoea by increasing
faecal mass and modulating gastrointestinal
motility.31 It has also been shown that increasing
soluble ﬁbre intake reduces the incidence and
severity of diarrhoea during radiotherapy.32
However, this ﬁbre used was psyllium seed
husk, a supplementary soluble ﬁbre and not food
soluble ﬁbre. Although psyllium is not routinely
provided in the department where this study was
undertaken ﬁbre supplements are recommended
in the information booklet by Macmillan Cancer
Support33 to manage bowel problems after pelvic
radiotherapy and therefore patients may take
supplemental soluble ﬁbre as it is readily available
over the counter.
During radiotherapy, a pilot study undertaken
among 60 patients showed a statistically signiﬁcant
reduction in the incidence of diarrhoea in those
who took one to two tsp of psyllium daily.34
Low-residue diets can be nutritionally inade-
quate and are not recommended for long periods
of time.35 Soluble ﬁbre is an essential nutrient for
gastrointestinal health because it is fermented by
colonic microbiota to produce short-chain fatty
acids, one of which is butyrate.36 Butyrate has
immunemodulatory and anti-inﬂammatory
actions which may negate some of the effects of
radiotherapy, suggesting that ﬁbre should not be
completely eliminated.36,37 This is illustrated
whereby the American Cancer Society38 does
not recommend excluding all ﬁbre but recom-
mends an increase in soluble ﬁbre foods.
Among the respondents, decreasing ﬁbre intake
was achieved by decreasing certain vegetables,
pulses, fruits and wholegrains. The vegetables
most commonly reduced included ﬁbrous and
raw vegetables. McGough et al.6 from their
review concluded that reduced intake of raw
vegetables is beneﬁcial in preventing acute
gastrointestinal symptoms. This is because these
foods can aggravate the lining of the bowel, which
has become inﬂamed following radiotherapy.39
Reducing caffeine, omitting alcohol, increasing
water intake and avoiding spicy foods is in agree-
ment with other dietary advice provided to alle-
viate diarrhoea as they stimulate the bowel.35,38
Ensuring adequate ﬂuid intake is important
for those who experience diarrhoea to avoid
dehydration and maintain electrolyte balance.40
As illustrated above reducing dairy and lactose
was recommended to participants in this study.
Avoiding dairy and lactose for the management
of diarrhoea is suggested by many authors.6,7,35,38
Although a small sample, three of those who
underwent chemotherapy (75%) suffered
from diarrhoea. One study illustrated that
5-ﬂuorouracil-based chemotherapy, which is a
standard chemotherapy regime for colorectal
cancer exacerbated the incidence of diarrhoea
and bloating on the premise that these patients
may have developed lactose intolerance.41
Therefore, in clinical practice recommending
the avoidance of dairy and or lactose may help
alleviate diarrhoea in some individuals under-
going pelvic radiotherapy and/or chemotherapy.
To help alleviate gas and ﬂatulence the advice
followed by patients in this study is in line with a
typical anti-ﬂatulent diet suggested by other
sources.42,43 Including reducing caffeine, avoid-
ing excessive dairy intake, reducing hot and spicy
foods, reducing gas-forming vegetables (onions
and brassica vegetables) and eating cooked
vegetables warm.43 Oates et al.,43 although a
small study with 30 participants showed that an
anti-ﬂatulent diet during radiotherapy reduces
rectal volume variability. However, this study
also used psyllium husk, which can minimise
abdominal distension, gas, and bloating because it
delays gastric emptying and reduces the accel-
eration of colon transit.34 This ﬁnding further
highlights the beneﬁt of including soluble ﬁbre in
these patients’ diet. However, caution should be
taken with patients who have decreased gut
motility and/or taking opioid pain medications
to prevent intestinal blockage.44
Although this study focusses on an important
area for concern, it has some limitations. First, the
majority of patients who were included in this
service evaluation had prostate cancer, however,
with prostate cancer being the most common
cancer among men in the United Kingdom,45 in
a study involving all patients undergoing pelvic
radiotherapy it is likely there will be an over
representation. In addition, the presentation of
Dietary advice provided to those undergoing pelvic radiotherapy
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gastrointestinal side effects depends on the type of
radiotherapy given, the dose given and treatment
time,46 therefore it would be beneﬁcial if these
treatment details were known.
CONCLUSION
Overall, pelvic radiotherapy affected patients’
dietary intake. The most common dietary advice
offered byHCPs and implemented by participants
in this study included restricting ﬁbre intake,
altering fruit and vegetable intake, increasing
water and decreasing caffeine. It is clear that more
dietary interventions aimed at decreasing symp-
toms are needed, especially for the management
of diarrhoea and gas and ﬂatulence as these were
the most common occurring side effects. Due to
the suggested beneﬁts of psyllium seed husk in the
management of gastrointestinal side effects further
research in this area is needed.
With the ﬁndings showing some conﬂicting
dietary advice being provided to patients it is
recommended that clear guidelines regarding
dietary advice for these patients are developed.
With radiographers most frequently giving
nutritional advice to these patients they must be
supported and provided with guidance regarding
clinical and dietary management to support those
undergoing pelvic radiotherapy.
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